Integra LifeSciences Cor...

NASDAQ: IART · Real-Time Price · USD
13.92
0.30 (2.20%)
At close: Aug 15, 2025, 12:11 PM

Integra LifeSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-6.94M 67.74M 180.55M 169.07M
Depreciation & Amortization
140.89M 123.51M 118.3M 119.84M
Stock-Based Compensation
24.38M 20.14M 27.73M 36.21M
Other Working Capital
-7.58M -6.17M 6.27M -27.35M
Other Non-Cash Items
-8.21M 22.02M -18.1M -28.1M
Deferred Income Tax
-20.73M -11.88M -4.58M -2.75M
Change in Working Capital
n/a -81.57M -39.42M 18.16M
Operating Cash Flow
129.38M 139.96M 264.47M 312.43M
Capital Expenditures
-104.42M -66.86M -47.09M -48.08M
Cash Acquisitions
-277.81M n/a -27.55M -113.44M
Purchase of Investments
-49M -32.69M -4.91M -76K
Sales Maturities Of Investments
54.5M 5.38M 4.91M 76K
Other Investing Acitivies
-14.08M n/a 16.05M 79K
Investing Cash Flow
-390.81M -94.18M -58.58M -161.44M
Debt Repayment
299.37M 54.5M -107.8M -100M
Common Stock Repurchased
-52.47M -275M -125M -4.8M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-9.04M -9.43M -24.62M 1.77M
Financial Cash Flow
237.86M -229.93M -251.95M -98.23M
Net Cash Flow
-30.03M -180.26M -56.79M 43.28M
Free Cash Flow
24.96M 73.09M 217.38M 264.35M